GlassScriptPhysician profile
Robert Shawn Smith
NPI 1083609135
$17,056.84
in general payments reported to CMS, 2019-2025
39 companies · $3,062 in 2025
The $3,062 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,155 · 2022: $4,212 · 2023: $2,673 · 2024: $2,955 · 2025: $3,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,091 · Consulting Fee: $563 · Education: $36.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,090.74 |
| Consulting Fee | $562.50 |
| Education | $36.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $6,080.20 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $1,474.95 | 2021-2025 | |
| Amgen INC. | $1,292.02 | 2021-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $1,057.69 | 2021-2025 | |
| Novo Nordisk INC | $887.13 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $672.12 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Exact Sciences Corporation | $603.36 | 2023-2025 | Cologuard Collection Kit |
| Modernatx, INC. | $562.50 | 2023 | Moderna Covid-19 Vaccine |
| Boehringer Ingelheim Pharmaceuticals, INC. | $515.06 | 2021-2025 | Jardiance |
| Corcept Therapeutics | $411.92 | 2025 | Korlym |
| Paratek Pharmaceuticals, INC. | $321.84 | 2022-2024 | Nuzyra |
| Pfizer INC. | $308.24 | 2021-2025 | |
| Boston Scientific Corporation | $302.97 | 2023-2025 | Ams 700, Wavewriter Alpha Prime 16, Lux-Dx Insertable Cardiac Monitor |
| Glaxosmithkline, LLC. | $262.31 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Abbott Laboratories | $261.36 | 2024 | Freestyle Libre 3 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.